Adalimumab for nail psoriasis: Efficacy and safety from the open-label extension of a phase-3, randomized, placebo-controlled trial

被引:0
|
作者
Gottlieb, Alice B. [1 ]
Elewski, Boni E. [2 ]
Okun, Martin M. [3 ]
Bagel, Jerry [4 ]
Poulin, Yves [5 ]
Gu, Yihua [6 ]
Williams, David A. [6 ]
Valdecantos, Wendell C. [6 ]
机构
[1] New York Med Coll, Valhalla, NY 10595 USA
[2] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[3] Ft Hlth Care, Ft Atkinson, WI USA
[4] Univ Med Ctr Princeton, Plainsboro, NJ USA
[5] Ctr Dermatolog Quebec Metropolitain, Quebec City, PQ, Canada
[6] AbbVie Inc, N Chicago, IL USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
4844
引用
收藏
页码:AB33 / AB33
页数:1
相关论文
共 50 条
  • [11] Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension
    Aman, Michael G.
    Findling, Robert L.
    Hardan, Antonio Y.
    Hendren, Robert L.
    Melmed, Raun D.
    Kehinde-Nelson, Ola
    Hsu, Hai-An
    Trugman, Joel M.
    Palmer, Robert H.
    Graham, Stephen M.
    Gage, Allyson T.
    Perhach, James L.
    Katz, Ephraim
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (05) : 403 - 412
  • [12] Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study
    Seok, Joon
    Koh, Young Gue
    Hong, Jun Ki
    Yun, So Hye
    Kim, Da Hye
    Son, Hyung Seok
    Choi, Sun Young
    Yoo, Kwang Ho
    Lee, Yang Won
    Kim, Beom Joon
    [J]. DERMATOLOGIC SURGERY, 2024, 50 (06) : 527 - 533
  • [13] SAFETY AND EFFICACY OF INCOBOTULINUMTOXINA FOR THE TREATMENT OF UPPER FACIAL LINES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY WITH OPEN-LABEL EXTENSION
    Trevidic, Patrick
    Connolly, Simon A.
    Biwer, Bernard
    Weissenberger, Petra
    Kestemont, Philippe
    Noah, Ernst M.
    Sattler, Gerhard
    Kerscher, Martina
    [J]. TOXICON, 2018, 156 : S110 - S110
  • [14] Efficacy and Safety of Pregabalin in Japanese Patients with Fibromyalgia: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase III Trial and Open-Label Extension Study
    Ohta, Hiroyoshi
    Ohkura, Masayuki
    Suzuki, Makoto
    Oka, Hiroshi
    Usui, Chie
    Nishioka, Kusuki
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S792 - S792
  • [15] RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION OF INTRANASAL OXYTOCIN FOR AUTISM SPECTRUM DISORDER
    Spanos, Marina
    Bethea, Terrence
    Alderman, Cheryl
    Johnson, Jacqueline
    Chandrasekhar, Tara
    Sikich, Linmarie
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S162 - S162
  • [16] Commentary on "Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study"
    Hausauer, Amelia K.
    [J]. DERMATOLOGIC SURGERY, 2024, 50 (06) : 534 - 534
  • [17] The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies
    Baldwin, David S.
    Chrones, Lambros
    Florea, Ioana
    Nielsen, Rebecca
    Nomikos, George G.
    Palo, William
    Reines, Elin
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (03) : 242 - 252
  • [18] Efficacy and safety of perampanel in a randomized, placebo-controlled trial with an open-label extension in patients with seizures associated with Lennox-Gastaut syndrome (LGS)
    Porter, Brenda
    Kira, Ryutaro
    Lee, Jeehun
    Aeby, Alec
    Patten, Anna
    Ngo, Leock
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [19] SAFETY AND EFFICACY OF MCC-257 IN DIABETIC PERIPHERAL NEUROPATHY: RESULTS OF A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL AND OPEN-LABEL EXTENSION
    Polydefkis, M.
    Arezzo, J.
    Katayama, S.
    Vinik, A., I
    Altman, H.
    [J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S110 - S110
  • [20] Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial
    Goldstone, Stephen E.
    Giuliano, Anna R.
    Palefsky, Joel M.
    Lazcano-Ponce, Eduardo
    Penny, Mary E.
    Cabello, Robinson E.
    Moreira, Edson D.
    Baraldi, Ezio
    Jessen, Heiko
    Ferenczy, Alex
    Kurman, Robert
    Ronnett, Brigitte M.
    Stoler, Mark H.
    Bautista, Oliver
    Das, Rituparna
    Group, Thomas
    Luxembourg, Alain
    Zhou, Hao Jin
    Saah, Alfred
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (03): : 413 - 425